Concepedia

SL Goldberg

SG

Statistics

Publications

4

Citations

144

H-Index

4

Active since

1997

Affiliations

Hackensack University Medical Center(Current)

Temple University

SL Goldberg is an author at Hackensack University Medical Center specializing in medicine, phase ii investigation, and hematology.

Publications per year

1997–2003

4

Publications

4

Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients.

SL Goldberg, Thomas R. Klumpp, A. J. Magdalinski et al. · Journal of Clinical Oncology · 1998 · 64 citations

Medicine, Hematology, Toxicology +16

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

AL Pecora, Pat Stiff, C.F. LeMaistre et al. · Bone Marrow Transplantation · 2001 · 36 citations

Medicine, Hematology, Cell Therapy +10

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy

Emil Bisaccia, Mark Palangio, José Núñez-González et al. · Bone Marrow Transplantation · 2003 · 31 citations

Life Sciences, Immunology, Surgery +7

Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment

TR Klumpp, SL Goldberg, A. J. Magdalinski et al. · Bone Marrow Transplantation · 1997 · 13 citations

Medicine, Oncology, Breast Oncology +16

1–4 of 4